I agree that this site is using cookies. You can find further informations here.
X
Montserrat, Emili
429  results:
Search for persons X
?
1

Spontaneous regression in chronic lymphocytic leukaemia. Cl..:

Del Giudice, Ilaria ; Cappelli, Luca Vincenzo ; Delgado, Julio...
British Journal of Haematology.  201 (2023)  2 - p. 353-356 , 2023
Link: https://doi.org/10.1111/..
 
?
2

Comparison Between Venetoclax-based and Bruton Tyrosine Kin..:

Molica, Stefano ; Giannarelli, Diana ; Montserrat, Emili
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  4 - p. 216-223 , 2021
Link: https://doi.org/10.1016/..
 
?
3

mRNA COVID‐19 vaccines in patients with chronic lymphocytic..:

Molica, Stefano ; Giannarelli, Diana ; Montserrat, Emili
European Journal of Haematology.  108 (2021)  3 - p. 264-267 , 2021
Link: https://doi.org/10.1111/..
 
?
4

Lymphocyte Doubling Time As A Key Prognostic Factor To Pred..:

Morabito, Fortunato ; Tripepi, Giovanni ; Moia, Riccardo...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
5

Lymphocyte doubling time in chronic lymphocytic leukemia mo..:

Baumann, Tycho ; Moia, Riccardo ; Gaidano, Gianluca...
Leukemia.  35 (2021)  8 - p. 2325-2331 , 2021
Link: https://doi.org/10.1038/..
 
?
6

FcγRIIb-BCR coligation inhibits BCR signaling in chronic ly..:

Bosch, Rosa ; Mora, Alba ; Cuellar, Carolina...
Haematologica.  106 (2020)  1 - p. 306-309 , 2020
Link: https://doi.org/10.3324/..
 
?
7

How We Manage Patients With Chronic Lymphocytic Leukemia Du..:

Rossi, Davide ; Shadman, Mazyar ; Condoluci, Adalgisa...
HemaSphere.  4 (2020)  4 - p. , 2020
Link: https://doi.org/10.1097/..
 
?
8

CLL and COVID-19 at the Hospital Clinic of Barcelona: an in..:

Baumann, Tycho ; Delgado, Julio ; Montserrat, Emili
Leukemia.  34 (2020)  7 - p. 1954-1956 , 2020
Link: https://doi.org/10.1038/..
 
?
9

The BALL prognostic score identifies relapsed/refractory CL..:

Molica, Stefano ; Baumann, Tycho S. ; Lentini, Mirella...
Leukemia Research.  95 (2020)  - p. 106401 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Ibrutinib as initial therapy in chronic lymphocytic leukemi..:

Molica, Stefano ; Giannarelli, Diana ; Baumann, Tycho.
European Journal of Haematology.  104 (2020)  5 - p. 512-515 , 2020
Link: https://doi.org/10.1111/..
 
?
11

Minimal Residual Disease and Survival Outcomes in Patients ..:

Molica, Stefano ; Giannarelli, Diana ; Montserrat, Emili
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  7 - p. 423-430 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Predicting the outcome of patients with chronic lymphocytic..:

Montserrat, Emili ; Gale, Robert Peter
Cancer.  125 (2019)  21 - p. 3699-3705 , 2019
Link: https://doi.org/10.1002/..
 
?
13

Critical molecular pathways in CLL therapy:

Ferrer, Gerardo ; Montserrat, Emili
Molecular Medicine.  24 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
14

Analysis of criteria for treatment initiation in patients w..:

Mozas, Pablo ; Rivas-Delgado, Alfredo ; Baumann, Tycho...
Blood Cancer Journal.  8 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
15

Changes in clinical stage identify patients with CLL and di..:

Moreno, Carol ; Delgado, Julio ; Byrd, John C....
British Journal of Haematology.  185 (2018)  1 - p. 148-150 , 2018
Link: https://doi.org/10.1111/..
 
1-15